Cholestyramine and medium-chain triglyceride in prolonged management of patients subjected to ileal resection or bypass.
The pathophysiology of cholerrheic enteropathy is described and a series of patients reviewed. Of 11 patients with chronic disabling diarrhea and steatorrhea after ileal resection or bypass, two had recurrent ileitis, three had lactose intolerance and six of those operated on five years or more previously had vitamin B(12) deficiency. Cholestyramine was given alone or with medium-chain triglyceride (MCT) or Portagen (MCT and lactose). The maximal response occurred when cholestyramine was given with Portagen - significantly reduced stool frequency and weight in all patients and stool fat in five. Restudy of five patients four to 11 months later showed the same pattern of response: cholestyramine with 70% MCT abolished symptoms in four patients (ileectomy) and 100% MCT alone greatly improved the condition of the fifth (extensive small bowel resection).
D000293:Adolescent; D000328:Adult; D002446:Celiac Disease / Q000188:drug therapy; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use*; D003967:Diarrhea / Q000188:drug therapy; D004041:Dietary Fats / Q000627:therapeutic use; D005243:Feces / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007079:Ileitis / Q000188:drug therapy; D007082:Ileum / Q000601:surgery*; D007410:Intestinal Diseases / Q000097:blood / Q000188:drug therapy*; D007785:Lactose / Q000627:therapeutic use; D007787:Lactose Intolerance / Q000188:drug therapy; D008055:Lipids / Q000032:analysis; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D013997:Time Factors; D014280:Triglycerides / Q000627:therapeutic use*; D014806:Vitamin B 12 Deficiency / Q000188:drug therapy; D014994:Xylose / Q000032:analysis
D004041:Dietary Fats; D008055:Lipids; D014280:Triglycerides; D002792:Cholestyramine Resin; D014994:Xylose; D007785:Lactose